SOC status:Duty analyst on shift

UK Cyber Defence
VulnerabilityModified

CVE-2023-31923

Suprema BioStar 2 before 2022 Q4, v2.9.1 has Insecure Permissions.

HIGH 8.8EPSS 0.86%

Does this matter?

High impact if exploited, but EPSS currently rates exploitation as unlikely (0.86%). Schedule it in the normal patch cycle and watch for a rise in EPSS or a public exploit.

Description

Suprema BioStar 2 before 2022 Q4, v2.9.1 has Insecure Permissions. A vulnerability in the web application allows an authenticated attacker with "User Operator" privileges to create a highly privileged user account. The vulnerability is caused by missing server-side validation, which can be exploited to gain full administrator privileges on the system.

CVSS 3.1
8.8 HIGHCVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
EPSS
0.86% probability · 57th percentile
CISA KEV
Not listed
Weakness
CWE-281
Affected
supremainc/biostar 2
Source
cve@mitre.org

Source: NVD record, EPSS from FIRST.org, KEV from CISA. Refreshed daily.